An article in the Communications of the AMC noted that “permissionless innovation” is the freedom to explore new technologies or businesses without seeking prior approval. It has already produced an explosion of goods and services in the IT industry. It improves efficiency and moves innovation closer to people with ideas. Permissionless innovation greatly increases the speed of invention and allows the ecosystem to provide ideas its system designers never had. The pharmaceutical industry could benefit from this approach.
Click here to read the full article.